Healthcare Equities

The companies that provide, support or coordinate medical goods and services. This sector spans a broad range of activities – including the development and manufacture of medical equipment, pharmaceuticals and other treatments. Activities range from research to manufacturing, administration, insurance and facilities management. Our Healthcare research includes healthcare services, healthcare information technology (IT), medical devices, biotechnology, biopharmaceuticals and specialty pharmaceuticals.

MagForce (MF6)

Latest price

-0.02

▾ 0.01 (100.00)

As at 09/06/2023

Market capitalisation: —

Healthcare

10.11.21

MagForce — Primed to execute on its growth strategy

Healthcare

10.11.21

MagForce — Primed to execute on its growth strategy

Healthcare

14.07.21

MagForce — Time to capitalise on growth potential

See more
content on

Mendus (IMMU)

Latest price

SEK0.99

▾ −0.35 (−26.12)

As at 09/06/2023

Market capitalisation: SEK200m

27.10.22

Mendus — Funding to see through key inflection points

18.10.22

Mendus — Next steps in anticipation of positive data

12.10.22

Mendus — Final EU grant payment of €1.69m expected

See more
content on

Molecure (MOC)

Latest price

PLN22.70

— 0.00 (0.00)

As at 09/06/2023

Market capitalisation: PLN318m

Newron Pharmaceuticals (NWRN)

Latest price

CHF4.29

▾ 0.04 (0.94)

As at 09/06/2023

Market capitalisation: CHF77m

Healthcare

15.09.22

Newron Pharmaceuticals — Evenamide catalyst approaching

Healthcare

01.11.21

Newron Pharmaceuticals — Pivotal progress on schizophrenia therapy

Healthcare

27.09.21

Newron Pharmaceuticals — Evenamide validation underway

See more
content on

Newron Pharmaceuticals

Nicox (ALCOX)

Latest price

EUR0.56

▾ −0.01 (−1.75)

As at 09/06/2023

Market capitalisation: EUR28m

Healthcare

22.09.22

Nicox — Revising NCX-470 timelines given Denali delay

Healthcare

21.07.22

Nicox — Moving towards key Mont Blanc data in Q4

Healthcare

07.06.22

Nicox — Mont Blanc top-line data timelines pushed forward

See more
content on

OpGen (OPGN)

Latest price

USD0.63

▾ 0.01 (1.61)

As at 09/06/2023

Market capitalisation: USD4m

Healthcare

04.10.22

OpGen — Unyvero UTI panel approaching final readouts

Healthcare

03.10.22

OpGen — $3.38m raised through private placement

Healthcare

20.09.22

OpGen — Unyvero A30 RQ collaboration with FIND

See more
content on

Oryzon Genomics (ORY)

Latest price

EUR2.29

▾ 0.22 (10.63)

As at 09/06/2023

Market capitalisation: EUR132m

Healthcare

16.09.22

Oryzon Genomics — Encouraging safety data in PORTICO

Healthcare

26.07.22

Oryzon Genomics — Preclinical collaboration in orphan disease

Healthcare

25.07.22

Oryzon Genomics — Costs up but company remains well funded

See more
content on

Oryzon Genomics

OSE Immunotherapeutics (OSE)

Latest price

EUR3.65

▾ −0.02 (−0.54)

As at 09/06/2023

Market capitalisation: EUR69m

Healthcare

23.09.22

OSE Immunotherapeutics — Tedopi remains focus in FY22

Healthcare

08.06.22

OSE Immunotherapeutics — Tedopi clinical data in NSCLC and PDAC

Healthcare

19.05.22

OSE Immunotherapeutics — First patient dosed with FR104/VEL-101

See more
content on

OSE Immunotherapeutics

Paradigm Biopharma (PAR)

Latest price

AUD0.93

▾ −0.01 (−1.07)

As at 09/06/2023

Market capitalisation: AUD259m

Pharnext (ALPHA)

Latest price

EUR0.71

▾ 0.71 (0.00)

As at 09/06/2023

Market capitalisation: —

06.03.23

Pharnext — Revised legal structure to offer operational stability

19.10.22

Pharnext — Funding headroom to support PXT3003 progress

06.10.22

Pharnext — €20.7m funding agreement with Neovacs inked

See more
content on

Pixium Vision (PIX)

Latest price

EUR0.07

— 0.00 (0.00)

As at 09/06/2023

Market capitalisation: EUR10m

Healthcare

20.09.22

Pixium Vision — PRIMAvera reaches full enrolment

Healthcare

14.09.22

Pixium Vision — First Prima implantation in Italy

Healthcare

04.08.22

Pixium Vision — Remote rehabilitation system approved

See more
content on

Quantum Genomics (ALQGC)

Latest price

EUR0.17

▾ −0.01 (−3.47)

As at 09/06/2023

Market capitalisation: EUR6m

Healthcare

30.08.22

Quantum Genomics — A fresh take on cardiovascular medicine

Healthcare

09.09.21

Quantum Genomics — Phase IIb QUORUM results

Healthcare

12.07.21

Quantum Genomics — Potentially transformational data in August

See more
content on

Quantum Genomics

Recce Pharmaceuticals (RCE)

Latest price

AUD0.56

▾ −0.03 (−5.08)

As at 09/06/2023

Market capitalisation: AUD100m

Renaissance BioScience (RENABIOTICKER)

Latest price

—

— 0.00 (0.00)

As at 09/06/2023

Market capitalisation: —

Healthcare

09.02.22

Renaissance BioScience: Edison Open House Healthcare 2022

Healthcare

21.01.22

Renaissance BioScience — RNAi technology from bioengineered yeast

See more
content on

Renaissance BioScience

ReNeuron Group (RENE)

Latest price

GBP0.08

▾ 1.80 (30.77)

As at 09/06/2023

Market capitalisation: GBP3m

09.12.22

ReNeuron Group — Encouraging data for iPSCs opens potential

07.10.22

ReNeuron Group — Differentiating in exosome drug delivery

Healthcare

08.10.21

ReNeuron Group — Extension trial to produce data in Q122

See more
content on

Respiri (RSH)

Latest price

AUD0.04

— 0.00 (−5.26)

As at 09/06/2023

Market capitalisation: AUD30m

Healthcare

22.09.22

Respiri — Objective measures for better outcomes

Healthcare

01.08.22

Respiri — Wheezo to begin patient use in the US

13.07.22

Respiri — NIHR funding to seek better outcomes

See more
content on

Load more

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free